INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 450m ago
HOUSE PTR50m ago
SEC 13F50m ago
ROBINHOOD CHAIN50m ago
SEC FORM 4/Grant or awardVerified dataRule 10b5-1 plan

Valantine Hannah reported CDNA

Director · CareDx, Inc. · Common Stock

Side
A
Value
—
Shares
9,795
Price
—
Executed
Jun 12, 2026
Disclosed
Jun 16, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jun 12 executedJun 16, 2026 disclosed

CDNA · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
7/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

No reported dollar value · 25.1% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CDNA

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    20
    CE
    Cohen Fred EDirector
    CDNACareDx, Inc.
    Gift
    		G—
    25.0K sh
    		Nov 3, 2026Nov 4, 2026
    traded Nov 3, 2026
    		+1dSEC FORM 4

    Evidence

    8
    NA
    Novack Jeffrey AdamSecretary and General Counsel
    CDNACareDx, Inc.
    Tax withholding
    		F$247K
    2,873 sh
    		Nov 1, 2026Nov 3, 2026
    traded Nov 1, 2026
    		+2dSEC FORM 4

    Evidence

    8
    NA
    Novack Jeffrey AdamSecretary and General Counsel
    CDNACareDx, Inc.
    Tax withholding
    		F$66K
    997 sh
    		Oct 1, 2026Oct 5, 2026
    traded Oct 1, 2026
    		+4dSEC FORM 4

    Evidence

    12
    MJ
    Meng JessicaChief Commercial Officer
    CDNACareDx, Inc.
    Tax withholding
    		F$173K
    2,619 sh
    		Oct 1, 2026Oct 5, 2026
    traded Oct 1, 2026
    		+4dSEC FORM 4

    Evidence

    15
    MJ
    Meng JessicaChief Commercial Officer
    CDNACareDx, Inc.
    Tax withholding
    		F$350K
    6,688 sh
    		Sep 12, 2026Sep 15, 2026
    traded Sep 12, 2026
    		+3dSEC FORM 4

    Evidence

    12
    MJ
    Meng JessicaChief Commercial Officer
    CDNACareDx, Inc.
    Tax withholding
    		F$71K
    2,411 sh
    		Jul 1, 2026Jul 2, 2026
    traded Jul 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    NA
    Novack Jeffrey AdamSecretary and General Counsel
    CDNACareDx, Inc.
    Tax withholding
    		F$29K
    997 sh
    		Jul 1, 2026Jul 2, 2026
    traded Jul 1, 2026
    		+1dSEC FORM 4

    Evidence

    5
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M$327K
    39.9K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    6
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$2,900
    100 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    0
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M$820
    100 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    8
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M$129K
    15.7K sh
    		Jun 15, 2026Jun 30, 2026
    traded Jun 15, 2026
    		+15dSEC FORM 4

    Evidence

    5
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M$5,789
    706 sh
    		Jun 4, 2026Jun 30, 2026
    traded Jun 4, 2026
    		+26dSEC FORM 4

    Evidence

    0
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M—
    39.9K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    0
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M—
    100 sh
    		Jun 26, 2026Jun 30, 2026
    traded Jun 26, 2026
    		+4dSEC FORM 4

    Evidence

    5
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M—
    15.7K sh
    		Jun 15, 2026Jun 30, 2026
    traded Jun 15, 2026
    		+15dSEC FORM 4

    Evidence

    5
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M—
    13.6K sh
    		Jun 11, 2026Jun 30, 2026
    traded Jun 11, 2026
    		+19dSEC FORM 4

    Evidence

    5
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M—
    706 sh
    		Jun 4, 2026Jun 30, 2026
    traded Jun 4, 2026
    		+26dSEC FORM 4

    Evidence

    19
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.17M
    39.9K sh
    		Jun 29, 2026Jun 30, 2026
    traded Jun 29, 2026
    		+1dSEC FORM 4

    Evidence

    8
    HW
    Hanna John Walter JRDirector, President and CEO
    CDNACareDx, Inc.
    Option exercise · 10b5-1 plan
    		M$112K
    13.6K sh
    		Jun 11, 2026Jun 30, 2026
    traded Jun 11, 2026
    		+19dSEC FORM 4

    Evidence

    24
    VH
    Valantine HannahDirector
    CDNACareDx, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$280K
    12.1K sh
    		Jun 15, 2026Jun 16, 2026
    traded Jun 15, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001855608-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 12, 2026
    Published
    Jun 16, 2026
    Ingested by INSIDER
    Nov 5, 03:52 UTC
    Last re-read
    Nov 5, 03:52 UTC

    Extracted facts

    Filer
    Valantine Hannah
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    CareDx, Inc.
    Ticker
    CDNA
    Shares
    9,795
    Price per share
    $0
    Execution date (reported)
    Jun 12, 2026
    Owned after transaction
    48.8K shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    4

    What this establishes

    Valantine Hannah filed this Form 4 reporting a grant or award of CDNA on Jun 12, 2026. It became public on Jun 16, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Valantine Hannahcik:0001855608
    Issuer
    CareDx, Inc.cik:0001217234

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.